The American Neurological Association Annual Meeting convenes top academic neurologists and neuroscientists, aiming to highlight groundbreaking conceptual and therapeutic advances in a variety of neurologic disease states, among other presentations.
ANX005 Demonstrates Safety in Huntington Disease, With Improvements Found in Subgroups of Patients
April 29th 2023In a subgroup of individuals with Huntington disease with high baseline C4a/C4 levels, treatment with ANX005 resulted in significant improvement in composite Unified Huntington’s Disease Rating Scale across all timepoints.